Boston Scientific Corporation

NYSE:BSX

Medical - Devices

Healthcare
$43.64 +1.00%

+$0.45 today

Market cap
$63.25B
Beta
0.56
P/E (TTM)
19.0
EPS (TTM)
$2.39
52W Low $44.44High $109.50

Volume 13.21M

Average 19.45M

BSX Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Boston Scientific CorporationNYSE: BSX

Weighted Avg Shares · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares dips below year-ago levels

Q2 FY2026 weighted avg shares of 1.48B shares fell 0.1% year over year, in line with the +0.4% change in trailing-twelve-month weighted avg shares. Sequentially, it fell 0.5% from the prior quarter. Over 3 fiscal years it compounded at +1.1% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -0.1% toward the trailing-twelve-month pace of +0.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
1.48B-0.5% QoQ
Last fiscal yearDec 2025
1.48B+0.6% YoY
LTMJun 2026
1.48B+0.4% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-0.1%——
1 year+0.6%——
3-year CAGR+1.1%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
1.48B USD
Year-over-year change
+0.6%
4-year CAGR
+1.0%

Weighted Avg Shares vs competitors

How BSX compares with its peers on the latest reported figures

  • BSX's LTM Jun 2026 weighted avg shares of 1.48B shares is the highest of the 11 companies compared; the peer median is 46.1M shares.
  • Its year-over-year change of +0.4% is the 7th highest of 11, against a peer median of +0.8%.
  • Over three fiscal years its annual growth of +1.1% compares with a peer median of +1.0%.
BSX Competitors Peer median
Weighted Avg Shares for BSX and competitors
Company Period LTM YoY 3-year CAGR
BSXBoston Scientific CorporationLTM Jun 20261.48B +0.4%+1.1%
MDTMedtronic plcLTM Jul 20261.28B -0.1%-1.2%
EWEdwards Lifesciences CorporationLTM Jun 2026580.18M -1.7%-1.9%
MMSIMerit Medical Systems, Inc.LTM Sep 202659.58M +1.1%+1.4%
LIVNLivaNova PLCLTM Sep 202654.83M +0.6%+0.6%
ATRCAtriCure, Inc.LTM Jun 202648.12M +1.8%+1.4%
TFXTeleflex IncorporatedLTM Jun 202644.07M -4.5%-1.6%
ANGOAngioDynamics, Inc.LTM Feb 202641.29M +1.4%+1.7%
PENPenumbra, Inc.LTM Jun 202639.21M +1.4%+0.9%
CNMDCONMED CorporationLTM Mar 202630.87M -0.0%+1.1%
CVRXCVRx, Inc.LTM Mar 202626.2M +12.8%+8.3%
Peer median (excluding BSX) 46.1M+0.8%+1.0%

Competitors are the stored peer set for BSX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue11.89B12.68B14.24B16.75B20.07B
Cost of Revenue4.43B4.97B5.41B6.48B6.22B
Gross Profit7.46B7.71B8.83B10.27B13.85B
Gross Margin62.8%60.8%62.0%61.3%69.0%
Research & Development1.2B1.32B1.41B1.62B2.05B
Selling, General & Admin4.29B4.52B5.19B5.98B6.89B
Operating Expenses5.54B5.89B6.65B7.63B9.88B
Depreciation & Amortization1.09B1.14B1.2B1.27B1.37B
EBITDA2.52B2.74B3.45B3.94B5.1B
EBITDA Margin21.2%21.6%24.2%23.5%25.4%
Operating Income1.92B1.82B2.18B2.64B3.97B
Operating Margin16.2%14.4%15.3%15.7%19.8%
Interest Income4M10M22M107M0
Interest Expense349M464M272M387M349M
Other Income / Expenses(846M)(683M)(196M)(353M)(586M)
Income Before Tax1.08B1.14B1.99B2.28B3.39B
Pre-Tax Margin9.1%9.0%13.9%13.6%16.9%
Income Tax Expense36M443M393M436M493M
Net Income1.04B698M1.59B1.85B2.89B
Net Margin8.7%5.5%11.2%11.1%14.4%
EPS (Basic)0.690.451.081.261.96
EPS (Diluted)0.690.451.071.251.94
Weighted Avg Shares1.42B1.43B1.45B1.47B1.48B
Weighted Avg Shares (Diluted)1.43B1.44B1.46B1.49B1.49B

Boston Scientific Corporation

NYSE:BSX

Intrinsic Alpha fair value

Locked

Current Price

$43.64

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.